跳至主要内容
临床试验/NCT00159289
NCT00159289撤回不适用

Effect of Endotoxin on Inflammatory Markers in Exhaled Breath, Sputum, Saliva and Nasal Lavage in Healthy Non-Smokers and Current Smokers Including Patients With COPD

Imperial College London2 个研究点 分布在 1 个国家开始时间: 2003年6月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
sputum induced

研究概览

简要总结

The primary aim of this study is to investigate the effects of inhaled lipopolysaccharide endotoxin (LPS) on bronchial and alveolar exhaled nitric oxide (NO) and NO metabolites and other inflammatory markers and mediators in exhaled breath condensate, induced sputum, nasal lavage and mouthwash fluid in healthy non-smokers and current smokers, including patients with chronic obstructive pulmonary disease (COPD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy non-smokers: normal spirometry (forced expiratory volume in 1 second [FEV1] more than or equal to 90% predicted) and normal exhaled NO (between 8 and 24 ppb; flow 50 ml/s)
  • 0: At risk (current or ex-smokers): normal spirometry, with or without chronic symptoms (cough, sputum production)
  • I-II: Mild-moderate COPD
  • FEV1 reversibility of < 15% after inhaled beta2-agonists
  • FEV1/forced vital capacity (FVC) < 70% predicted
  • FEV1 between greater than or equal to 50% and less than 80%
  • With or without chronic symptoms (cough, sputum production)
  • Able to comprehend and grant a written informed consent

排除标准

  • Concomitant use or pre-treatment within the last 4 weeks with oral steroids
  • Respiratory infection within 4 weeks prior to entry into the trial
  • Females who are pregnant or lactating
  • History of current or past drug or alcohol abuse

结局指标

主要结局

sputum induced

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验